BGVCX Mutual Fund

NAV$34.64

Fund Essentials - as of Mar 31, 2026

Net Assets
$2M
Expense Ratio
2.00%
Dividend Yield (Current)
11.29%
Holdings
72
Inception Date
Jan 31, 2013
Fund Family
Brandes Investment Partners
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Quarterly
SEC 30-Day Yield
••••••••••

Performance

YTD+4.34%
1 Year+15.86%
3 Year+18.39%
5 Year+12.40%
10 Year+11.35%

Asset Allocation

Stocks: 97.59%
Cash: 2.42%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
GSK:LNGlaxosmithkline Pharmaceutic 2.81%
TTETotalEnergies SE SPONSORED ADS2.71%
SASY:PASanofi SA2.63%
SHELShell Plc2.55%
NTPXXNorthern Institutional Treasury Portfolio2.41%
Top 10 Concentration: 23.74%Report Date: Mar 31, 2026
Download all 72 holdings for BGVCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
11.29%
Frequency
Quarterly
Latest Distribution
$0.13
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

BGVCX Mutual Fund Overview

BGVCX Mutual Fund (Brandes Global Equity Fund Class C) is managed by Brandes Investment Partners with $1.5M in net assets. BGVCX expense ratio is 2.00%, holding 72 positions across sectors including Unknown, Health Care, Financials. Inception date: 2013-01-31.

BGVCX performance shows a YTD return of 4.34%. The 1-year return is 15.86% and the 5-year return is 12.40%. BGVCX dividend yield stands at 11.29%, paid quarterly.

BGVCX top holdings include Glaxosmithkline Pharmaceutic (2.8%), TotalEnergies SE SPONSORED ADS (2.7%), Sanofi SA (2.6%), Shell Plc (2.5%), Northern Institutional Treasury Portfolio (2.4%). View all BGVCX holdings, sector breakdown, or dividend history.

BGVCX can be compared against other funds using the overlap calculator or side-by-side comparison tool. BGVCX alternatives are available via the screener, along with tax-loss harvesting opportunities.